Found: 32
Select item for more details and to access through your institution.
Tocilizumab in Treatment for Patients With COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Survival and proliferation factors of normal and malignant plasma cells.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 493, doi. 10.3390/vaccines11030493
- By:
- Publication type:
- Article
Targeted Therapies in Adult B-Cell Malignancies.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.919489
- By:
- Publication type:
- Article
Phase-I/II radio-immunotherapy study with iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab′).
- Published in:
- International Journal of Cancer, 1998, v. 75, n. 4, p. 615, doi. 10.1002/(SICI)1097-0215(19980209)75:4<615::AID-IJC20>3.0.CO;2-6
- By:
- Publication type:
- Article
Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma.
- Published in:
- International Journal of Cancer, 1997, v. 72, n. 3, p. 424, doi. 10.1002/(SICI)1097-0215(19970729)72:3<424::AID-IJC9>3.0.CO;2-R
- By:
- Publication type:
- Article
Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 1, p. e28, doi. 10.1111/bjh.17177
- By:
- Publication type:
- Article
Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0042161
- By:
- Publication type:
- Article
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells.
- Published in:
- Oncogene, 2005, v. 24, n. 21, p. 3512, doi. 10.1038/sj.onc.1208536
- By:
- Publication type:
- Article
Microarray-based understanding of normal and malignant plasma cells.
- Published in:
- Immunological Reviews, 2006, v. 210, n. 1, p. 86, doi. 10.1111/j.0105-2896.2006.00362.x
- By:
- Publication type:
- Article
Phase I study of atacicept in relapsed/refractory multiple myeloma (MM) and Waldenström's macroglobulinemia.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Phase I Study of Atacicept in Relapsed/Refractory Multiple Myeloma (MM) and Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 136, doi. 10.3816/CLML.2011.n.031
- By:
- Publication type:
- Article
Controlled Epstein- Barr virus reactivation after allogeneic transplantation is associated with improved survival.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 5, p. 421, doi. 10.1111/ejh.12260
- By:
- Publication type:
- Article
APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
- Published in:
- European Journal of Haematology, 2009, v. 83, n. 2, p. 119, doi. 10.1111/j.1600-0609.2009.01262.x
- By:
- Publication type:
- Article
Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type.
- Published in:
- American Journal of Hematology, 1988, v. 29, n. 4, p. 183, doi. 10.1002/ajh.2830290402
- By:
- Publication type:
- Article
Azoximer bromide and hydroxyapatite: promising immune adjuvants in cancer.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 12, p. 1021, doi. 10.20892/j.issn.2095-3941.2023.0222
- By:
- Publication type:
- Article
Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.595722
- By:
- Publication type:
- Article
REGRESSION OF EXCESSIVE BONE REMODELLING BY INTERFERON ALPHA-2-A IN A PATIENT WITH HAIRY CELL LEUKEMIA: To the Editor:.
- Published in:
- European Journal of Haematology, 1988, v. 41, n. 2, p. 191, doi. 10.1111/j.1600-0609.1988.tb00892.x
- By:
- Publication type:
- Article
CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0150434
- By:
- Publication type:
- Article
Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 3, p. 386, doi. 10.1111/j.1365-2141.2012.09169.x
- By:
- Publication type:
- Article
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 2, p. 159, doi. 10.1111/j.1365-2141.2010.08329.x
- By:
- Publication type:
- Article
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 350, doi. 10.1111/j.1365-2141.2009.07633.x
- By:
- Publication type:
- Article
Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 1, p. 45, doi. 10.1111/j.1365-2141.2008.07562.x
- By:
- Publication type:
- Article
In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 2, p. 206, doi. 10.1111/j.1365-2141.2007.06754.x
- By:
- Publication type:
- Article
Targeting NF- κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 2, p. 160, doi. 10.1111/j.1365-2141.2007.06629.x
- By:
- Publication type:
- Article
Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production.
- Published in:
- British Journal of Haematology, 1998, v. 103, n. 4, p. 1152, doi. 10.1046/j.1365-2141.1998.01101.x
- By:
- Publication type:
- Article
The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells.
- Published in:
- British Journal of Haematology, 1998, v. 100, n. 4, p. 637, doi. 10.1046/j.1365-2141.1998.00623.x
- By:
- Publication type:
- Article
Interleukin 2 production in bone marrow of normal individuals and patients associated with B-cell chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 1988, v. 68, n. 2, p. 207, doi. 10.1111/j.1365-2141.1988.tb06191.x
- By:
- Publication type:
- Article
MULTIPLE MYELOMA: OPTIMAL USE OF SALMON CALCITONIN IN THE MANAGEMENT OF MYELOMA OSTEOCLASTIC BONE DISEASE.
- Published in:
- British Journal of Haematology, 1983, v. 53, n. 1, p. 170, doi. 10.1111/j.1365-2141.1983.tb02002.x
- By:
- Publication type:
- Article
Growth factors in multiple myeloma: acomprehensive analysis of their expression intumor cells and bone marrow environment usingAffymetrix microarrays.
- Published in:
- BMC Cancer, 2010, v. 10, p. 198, doi. 10.1186/1471-2407-10-198
- By:
- Publication type:
- Article